RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 88 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $566,897 | +129.5% | 103,484 | +309.7% | 0.00% | – |
Q4 2021 | $247,000 | -44.6% | 25,259 | +1.1% | 0.00% | – |
Q3 2021 | $446,000 | -31.1% | 24,972 | -5.7% | 0.00% | -100.0% |
Q2 2021 | $647,000 | +11.7% | 26,488 | +21.2% | 0.00% | 0.0% |
Q1 2021 | $579,000 | +204.7% | 21,860 | -12.6% | 0.00% | – |
Q4 2020 | $190,000 | +58.3% | 25,021 | +4.0% | 0.00% | – |
Q3 2020 | $120,000 | -21.1% | 24,048 | 0.0% | 0.00% | – |
Q2 2020 | $152,000 | +38.2% | 24,048 | -2.6% | 0.00% | – |
Q1 2020 | $110,000 | -49.8% | 24,702 | +6.9% | 0.00% | – |
Q4 2019 | $219,000 | +15.3% | 23,097 | -3.0% | 0.00% | – |
Q3 2019 | $190,000 | -47.7% | 23,812 | +3.2% | 0.00% | – |
Q2 2019 | $363,000 | +48.8% | 23,078 | +70.9% | 0.00% | – |
Q1 2019 | $244,000 | – | 13,505 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 2,618,351 | $41,187,000 | 42.64% |
Flagship Pioneering Inc. | 38,296,526 | $602,404,000 | 26.08% |
HARBOURVEST PARTNERS LLC | 1,973,756 | $31,048,000 | 5.81% |
Artal Group S.A. | 2,833,791 | $44,576,000 | 1.80% |
EcoR1 Capital, LLC | 463,152 | $7,285,000 | 0.74% |
Cormorant Asset Management, LP | 600,000 | $9,438,000 | 0.54% |
Nikko Asset Management Americas, Inc. | 1,254,158 | $19,728,000 | 0.39% |
Leap Investments LP | 14,100 | $222,000 | 0.30% |
ARK Investment Management | 698,402 | $10,986,000 | 0.28% |
Baillie Gifford | 4,234,682 | $66,612,000 | 0.07% |